Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.4113
-0.0187 (-4.35%)
At close: Sep 17, 2025, 4:00 PM EDT
0.4250
+0.0137 (3.33%)
Pre-market: Sep 18, 2025, 8:48 AM EDT
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $59.23 million as of September 18, 2025. Its market cap has decreased by -91.87% in one year.
Market Cap
59.23M
Enterprise Value
31.41M
1-Year Change
-91.87%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has decreased from $160.29M to $59.23M, a decrease of -63.05%. That is a compound annual growth rate of -14.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 59.23M | -40.54% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |